Baker's Corner Bakery Oatmeal Cranberry Cookie, packed in closed bags, 12oz net wt recall — FDA F-1010-2021
Shortening is declared but sub-ingredient Soybean Oil is not declared.
Complete FDA and NHTSA recall records dated in 2021, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Shortening is declared but sub-ingredient Soybean Oil is not declared.
Product contains sulfites, FD&C Yellow #5, and coconut
Product may contain undeclared sesame seeds.
The firm determined that the food was not held at an appropriate temperature. Because of the time-temperature relationship of the environment this food could be unsafe to consume.
Product contains high levels of undeclared sulfites.
The firm determined that the food was not held at an appropriate temperature. Because of the time-temperature relationship of the environment this food could be unsafe to consume.
The firm determined that the food was not held at an appropriate temperature. Because of the time-temperature relationship of the environment this food could be unsafe to consume.
The firm determined that the food was not held at an appropriate temperature. Because of the time-temperature relationship of the environment this food could be unsafe to consume.
Undeclared sulfites
The firm determined that the food was not held at an appropriate temperature. Because of the time-temperature relationship of the environment this food could be unsafe to consume.
The firm determined that the food was not held at an appropriate temperature. Because of the time-temperature relationship of the environment this food could be unsafe to consume.
The firm determined that the food was not held at an appropriate temperature. Because of the time-temperature relationship of the environment this food could be unsafe to consume.
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
Lack of Assurance of Sterility
Microbial Contamination of Non-Sterile Product: Out-of-specification results obtained for total aerobic microbial count (TAMC).
Subpotency: one product for active ingredient assay and another one for preservative assay
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
Subpotency: one product for active ingredient assay and another one for preservative assay
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
CGMP Deviations
Failed Dissolution Specifications
Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.